Show simple item record

dc.contributor.authorBasta, Nen
dc.contributor.authorHalliday, Gen
dc.contributor.authorMakin, Guy W Jen
dc.contributor.authorBirch, Jen
dc.contributor.authorFeltbower, Ren
dc.contributor.authorBown, Nen
dc.contributor.authorElliott, Men
dc.contributor.authorMoreno, Len
dc.contributor.authorBarone, Gen
dc.contributor.authorPearson, Aen
dc.contributor.authorJames, Pen
dc.contributor.authorTweddle, Den
dc.contributor.authorMcNally, Ren
dc.date.accessioned2016-11-18T12:46:44Z
dc.date.available2016-11-18T12:46:44Z
dc.date.issued2016-10-25
dc.identifier.citationFactors associated with recurrence and survival length following relapse in patients with neuroblastoma. 2016, 115 (9):1048-1057 Br J Canceren
dc.identifier.issn1532-1827
dc.identifier.pmid27701387
dc.identifier.doi10.1038/bjc.2016.302
dc.identifier.urihttp://hdl.handle.net/10541/620024
dc.description.abstractDespite therapeutic advances, survival following relapse for neuroblastoma patients remains poor. We investigated clinical and biological factors associated with length of progression-free and overall survival following relapse in UK neuroblastoma patients.
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titleFactors associated with recurrence and survival length following relapse in patients with neuroblastoma.en
dc.typeArticleen
dc.contributor.departmentInstitute of Health & Society, Newcastle University, Newcastle upon Tyne, UKen
dc.identifier.journalBritish Journal of Canceren
html.description.abstractDespite therapeutic advances, survival following relapse for neuroblastoma patients remains poor. We investigated clinical and biological factors associated with length of progression-free and overall survival following relapse in UK neuroblastoma patients.


This item appears in the following Collection(s)

Show simple item record